190 top medical experts on Hyperlipoproteinemia Type III across 16 countries and 11 U.S. states, including 36 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Hyperlipoproteinemia Type III: An autosomal recessively inherited disorder characterized by the accumulation of intermediate-density lipoprotein (IDL or broad-beta-lipoprotein). IDL has a cholesterol to triglycerides ratio greater than that of very-LOW-density lipoproteins. This disorder is due to mutation of apolipoproteins E, a receptor-binding component of vldl and chylomicrons, resulting in their reduced clearance and high plasma levels of both cholesterol and triglycerides.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Inborn Errors Lipid Metabolism (797), Hyperlipoproteinemias (515).
  4. Clinical Trials ClinicalTrials.gov : at least 6 including 1 Completed, 2 Recruiting
  5. Synonyms: Broad Beta Disease,  Dysbetalipoproteinemia,  Familial Dysbetalipoproteinemia


  

        

                    


    Computing Expert Listing ...

);